Tag Archives: MedView

Patient medication safety improvements to be examined by Fred IT Group

Fred will lead a new medicines safety project to explore the impact of digital health records in improving patient medication safety for the Australian Digital Health Agency.

The medicines safety project is one of 15 Digital Health Test Beds announced on Tuesday by The Hon. Greg Hunt, MP Minister for Health. The project will investigate the impact of digital health systems in supporting patient medication safety and clinical decision-making as patients move between the care of their community pharmacy and hospital settings.

According to Fred CEO and pharmacist Paul Naismith, digital health systems can provide significant value to clinical and patient support as patients move through these settings.

Hospital, community pharmacy and GP settings have evolved with different clinical systems which means that they have not necessarily spoken to each other. This has meant that real-time medications management and reconciliation is not necessarily visible to all parties as patients move between these different care settings, with concerning implications for clinical decision-making and patient safety. 

 Fred believes that digital systems have a fundamental role to play in bridging gaps such as these in patient medicines history between different pharmacy settings. We are delighted to be involved in the process of gathering evidence about the real impact that digital health records have in strengthening medications management and patient outcomes .  

Fred, together with partners including the Pharmacy Guild of Australia and Monash University will measure the impact of digital medications reconciliation on patient medication safety and improving access to clinical decision-making data, using information from Fred’s existing clinical tool, MedView together with the My Health Record.

Click here to view the Fred IT Group media release
‘Improving patient healthcare through digital trials’, Australian Digital Health Agency, 3 July 2018

eRx Script Exchange hits 2 billion clinical records

As pharmacy enters its busiest dispensing period of the year, eRx Script Exchange has achieved the significant milestone of 2 billion clinical records whilst also delivering the majority of electronic prescriptions in less than 1 second.

With more than 22,000 GPs and 90% of Australian community pharmacies using eRx, this means that the clinical data on prescriptions and dispenses available to the MyHR has grown significantly in the 8 years since eRx was launched in 2009. The first billion electronic clinical records occurred in a little over six years (between May 2009 and July 2015), whilst the second billion took a little over two years.

According to David Freemantle, General Manager of eHealth for Fred IT Group, this achievement of 2 billion clinical transactions demonstrates the significant progression of eHealth in Australia over recent years.

This is the first time that an Australian health information exchange has reached the critical mass of 2 billion clinical records. This is a significant milestone in terms of demonstrating the ongoing advances being made in eHealth in Australia, as well as in delivering tangible benefits of safer and more efficient dispensing to the majority of pharmacists and their patients throughout Australia. 

With 7.6 million prescribe and dispense events expected in the week leading up to Christmas Day, speed and reliability enhancements continue to support the ability of pharmacists to ensure the safety of their patients in these busy times. Over the past 12 months these speed and reliability enhancements have meant:

  • 99% of all scripts are now delivered in less than 3 seconds
  • 90% of scripts are delivered in under 1 second – a significant improvement upon the 60% of scripts delivered in this timeframe 12 months ago

eRx safer & faster

According to David Freemantle,

Reaching 2 billion records is an outstanding outcome and paves the way for services that have the ability to break down the medication data silos prevalent across the health sector and to enable health practitioners to make more informed clinical decisions regarding their patient’s care. 

New clinical tools and services are already exploring how, with patient consent and appropriate security and safety checks, patient medications information can extend clinical decision-making, with the potential for saving lives, including:

MedView Medicines List

A consolidated medications history that is currently being used in two Victorian hospitals for medications reconciliation on admission, and available to community pharmacies for a range of medications management services.

SafeScript

The real-time prescription monitoring system recently announced by the Victorian Department of Human Services to help prevent prescription medication misuse and save lives. Fred has been appointed to develop SafeScript for roll out in Victoria in 2018.

Click here to view the full media release


Find out why 90% of pharmacies and over 20,000 doctors trust eRx


MedView Medicines Workspace – Bridging the gap between acute and community care

One of the key problems facing Australian health care professionals continues to be the lack of consolidated medications information and an inability to easily share information between health professionals. When patients move between community care and hospital and aged care, the absence of good quality and up to date clinical data can contribute to these interactions becoming high risk, resulting in medication misadventures and unnecessary hospital readmissions.

Medications reconciliation remains a largely manual process throughout Australia, providing a glaring reminder of the implications around the lack of shared clinical data on patient welfare. Thankfully, technology advances are making significant inroads into this problem, with the development of new applications such as the MedView Medicines Workspace.

MedView Medicines WorkspaceThe MedView Medicines Workspace is an update on the original MedView pilot which took place in the Barwon Region of Victoria. The pilot tackled the problem around the lack of visibility of clinical data between different sectors, drawing together medication information from healthcare professionals in community, hospital and aged care settings. As a result and in an Australian first, health professionals who took part in the trial were able to see a combined list of patients’ prescribed and dispensed medications from across all of these settings.

The pilot found that the sharing of clinical data, with patient consent, resulted in better medications management and safer outcomes for patients. MedView demonstrated the capacity of web applications to draw on data captured by existing systems, especially eRx Script Exchange, as a way of delivering extra value for health users and health professionals.

In community pharmacy and GP clinics, it is not uncommon to see patients who are confused about what medications they should be taking according to their discharge summary. The MedView Medicines Workspace will help alleviate this problem by allowing doctors, pharmacists, hospitals, aged care settings and patients to have shared access to critical medicines information and services.

With MedView Medicines Workspace, authorised health care providers will be able to view hospital data and pharmacy data at the same time, regardless of whether they are in My Health Record (MyHR) or MedView. They can then curate the data into a reconciled list, which can also be verified with additional input from the patient. Should the patient then present at a hospital or clinic, the clinician can view the reconciled list, complete with details on who curated the list and when, enabling a well-informed discussion with the patient about their medication.

The MedView pilot was focused solely on providing a consolidated list of all prescribed and dispensed medications of a patient for practitioners to see. This was a significant achievement in itself, however there was no capacity to interact directly with the data provided and improve the quality of the information held.

Four years on and taking it a step further, the new MedView Medicines Workspace will be a hub for authorised third parties to integrate with and deliver additional medications management services such as, medications reconciliation, medications monitoring and compliance monitoring – allowing clinicians to contribute data back to MyHR.

The original MedView provided a consolidated medications list of prescribe and dispense events. The new MedView will provide services on top which will help drive meaningful use of MyHR data.

With the launch of MedView Medications Workspace on the horizon, we will be in a stronger position to ensure that the right health care professionals are able to see the right information at the right time. Above and beyond this, doctors, pharmacists and other clinicians will also be able to contribute to shared records, both within the workspace and in MyHR. Not only can this help to ease the burden of misadventure and unnecessary hospital readmissions, but it also has real potential to drive the meaningful use of MyHR.

The key, as an industry, is to concentrate on bridging these information gaps to provide optimal care for patients. The ideal of one clear and perfect complete source of medications data is still a way off, however we must concentrate our efforts on how we can better work together as an industry to use data that is already being captured through systems such as electronic prescribing and dispensing. In this view, MedView Medicines Workspace and MyHR are not competing, but rather are complementary ways of building up clinical data at some of the high risk intersections between care settings.

It goes without saying that any such understanding needs to be based on the view that data is only shared with consent, and that it is dealt with sensitively and with a view to improving health outcomes rather than commercial outcomes.

The MedView Medicines Workspace is a prime example of how thinking creatively and applying innovation can deliver real life-saving potential and immediate practical value to the entire health sector.